Security key
92840H400
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)
CUSIP: 92840H400
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 41,041,331
- Total 13F shares
- 13,134,779
- Share change
- -7,609,434
- Total reported value
- $8,693,359
- Put/Call ratio
- 72%
- Price per share
- $0.66
- Number of holders
- 53
- Value change
- -$30,764,910
- Number of buys
- 31
- Number of sells
- 29
Report period
Q4 2025
Institutions
53
Top holders
10
VTGN full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Vistagen Therapeutics, Inc. SEC filings
Vistagen Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92840H400
Recent filing periods:
Top shareholders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
10%
|
3,084,324
|
$7,217,318 | $0 | 31 Dec 2024 | |
| Commodore Capital LP |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
9.9%
from 13D/G
|
1,575,000
|
$5,591,250 | — | 30 Sep 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
|
— |
5%
|
2,055,834
|
$1,521,317 | $0 | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
1,978,492
|
$7,023,647 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
4.6%
from 13D/G
|
1,687,735
|
$5,991,460 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company · ORBIMED CAPITAL LLC |
4.2%
from 13D/G
|
3,060,000
|
$10,863,000 | — | 30 Sep 2025 | |
| STEMPOINT CAPITAL LP |
13F
13D/G
|
Company |
1.5%
from 13D/G
|
2,488,685
|
$7,749,263 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
10%
|
4,165,767
|
$14,746,815 | — | 30 Sep 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
6.5%
|
2,676,580
|
$9,501,859 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.5%
|
620,869
|
$2,204,084 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.3%
|
550,000
|
$1,952,500 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
423,128
|
$1,502,105 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1%
|
422,012
|
$1,498,143 | — | 30 Sep 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.85%
|
349,789
|
$1,241,751 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.74%
|
302,683
|
$1,074,525 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
298,280
|
$1,059,256 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.71%
|
289,409
|
$1,027,402 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.66%
|
271,825
|
$964,979 | — | 30 Sep 2025 | |
| Almitas Capital LLC |
13F
|
Company |
0.64%
|
261,399
|
$927,966 | — | 30 Sep 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.5%
|
206,998
|
$734,843 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
197,024
|
$699,435 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.38%
|
157,032
|
$557,464 | — | 30 Sep 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
0.37%
|
150,000
|
$532,500 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
122,062
|
$433,320 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.28%
|
113,062
|
$401,370 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
96,858
|
$343,846 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
85,594
|
$303,859 | — | 30 Sep 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.18%
|
75,319
|
$267,382 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.17%
|
69,712
|
$247,478 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
68,017
|
$241,397 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.17%
|
67,770
|
$240,584 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
60,152
|
$213,540 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
48,093
|
$170,730 | — | 30 Sep 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.11%
|
43,953
|
$156,033 | — | 30 Sep 2025 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.1%
|
42,704
|
$151,599 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.1%
|
41,072
|
$145,806 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
34,657
|
$123,032 | — | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.08%
|
31,486
|
$112,000 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.07%
|
28,928
|
$102,694 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
27,534
|
$97,746 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
25,667
|
$91,118 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
23,302
|
$82,722 | — | 30 Sep 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.05%
|
20,828
|
$73,939 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
20,676
|
$73,400 | — | 30 Sep 2025 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.05%
|
20,033
|
$71,117 | — | 30 Sep 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.04%
|
15,752
|
$55,762 | — | 30 Sep 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.03%
|
12,573
|
$44,634 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.03%
|
10,883
|
$38,633 | — | 30 Sep 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0.02%
|
8,655
|
$30,725 | — | 30 Sep 2025 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.01%
|
6,000
|
$21,000 | — | 30 Sep 2025 |
Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q4 2025
As of 31 Dec 2025,
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,134,779 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, TCG Crossover Management, LLC, VANGUARD GROUP INC, ADAR1 Capital Management, LLC, JANE STREET GROUP, LLC, Ikarian Capital, LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, LUMINUS MANAGEMENT LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
58
Q4 2025 holders
53
Holder diff
-5
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.